Managed Access Programs for BYL719, Alpelisib
Novartis
Novartis
CG Oncology, Inc.
Children's Hospital of Philadelphia
Novartis
Gilead Sciences
Nuvalent Inc.
Cogent Biosciences, Inc.
SpringWorks Therapeutics, Inc.
Regeneron Pharmaceuticals
Bayer
SpringWorks Therapeutics, Inc.
ImmunityBio, Inc.
ITM Solucin GmbH
Memorial Sloan Kettering Cancer Center
Cogent Biosciences, Inc.
Aveni Foundation
Karyopharm Therapeutics Inc
Autolus Limited
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Milton S. Hershey Medical Center
Nuvalent Inc.
Janssen Scientific Affairs, LLC
USWM, LLC (dba US WorldMeds)
AbbVie
AbbVie
AbbVie
AbbVie
xCures
Jaime Leandro Foundation for Therapeutic Cancer Vaccines
Incyte Corporation
OHSU Knight Cancer Institute
Regeneron Pharmaceuticals
Celgene
Juno Therapeutics, a Subsidiary of Celgene
Novartis
Novartis
Rezolute
Gilead Sciences
Duke University
Novartis
University of California, San Francisco
St. Jude Children's Research Hospital
AVM Biotechnology Inc
Eli Lilly and Company
Astellas Pharma Inc
Institute of Hematology & Blood Diseases Hospital, China
Baylor College of Medicine
Second Life Therapeutics
University of California, San Francisco
Telix Pharmaceuticals (Innovations) Pty Limited